A
IOVA icon

AlphaQuest’s Iovance Biotherapeutics IOVA Stock Holding History

AlphaQuest’s Portfolio IOVA Stock Details IOVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-315
Closed -$860 – 995
2025
Q4 		$860 Hold
315
– – ﹤0.01% 2214
2025
Q3 		$684 Hold
315
– – ﹤0.01% 2212
2025
Q2 		$542 Hold
315
– – ﹤0.01% 1938
2025
Q1 		$1.05K Sell
315
-4,298
-93% -$22.2K ﹤0.01% 1926
2024
Q4 		$34.1K Buy
4,613
+1,794
+64% +$16.6K ﹤0.01% 1359
2024
Q3 		$26.5K Sell
2,819
-2,184
-44% -$20.7K ﹤0.01% 1489
2024
Q2 		$40.1K Buy
5,003
+4,629
+1,238% +$49.6K 0.01% 1128
2024
Q1 		$5.54K Buy
+374
New +$4.35K ﹤0.01% 1095

Other funds holding IOVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
MFM
MHR Fund Management New York $1.92B AUM 119.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
ICM
Invenomic Capital Management Boston, Massachusetts $1.67B AUM 1.43% 1-Year Est. Return

AlphaQuest's IOVA Position: Q1 2026 in Review

AlphaQuest sold out of Iovance Biotherapeutics (IOVA) in Q1 2026, closing a stake of 315 shares — an estimated $860 sold.

AlphaQuest first reported a position in IOVA in Q1 2024 and held it in 8 quarters. The position peaked at $40.1K in Q2 2024. 286 funds tracked by Wall St. Rank hold IOVA as of Q1 2026.

  • AlphaQuest reported no remaining Iovance Biotherapeutics position as of Q1 2026 after selling out during the quarter.
  • AlphaQuest sold 315 Iovance Biotherapeutics shares in Q1 2026, an estimated $860.
  • AlphaQuest first reported a position in Iovance Biotherapeutics in Q1 2024 and held it in 8 quarters.
  • AlphaQuest's Iovance Biotherapeutics position peaked at $40.1K in Q2 2024.
  • 286 funds tracked by Wall St. Rank held Iovance Biotherapeutics as of Q1 2026.

Based on AlphaQuest's 13F filing for Q1 2026.